Insulet Corporation [PODD] stock is trading at $277.20, down -0.61%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PODD shares have gain 4.85% over the last week, with a monthly amount glided 8.04%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insulet Corporation [NASDAQ: PODD] stock has seen the most recent analyst activity on November 06, 2024, when Bernstein initiated its Outperform rating and assigned the stock a price target of $300. Previously, Redburn Atlantic started tracking the stock with Buy rating on May 30, 2024, and set its price target to $235. On May 07, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $200 on the stock. Robert W. Baird upgraded its rating to a Outperform and increased its price target to $238 on December 21, 2023. Morgan Stanley upgraded its rating to a Overweight and raised its price target to $234 on December 04, 2023. Jefferies upgraded its rating to Buy for this stock on October 02, 2023, and downed its price target to $240. In a note dated August 21, 2023, Citigroup upgraded an Buy rating on this stock and revised its target price from $273 to $265.
Insulet Corporation [PODD] stock has fluctuated between $160.19 and $282.86 over the past year. Currently, Wall Street analysts expect the stock to reach $268 within the next 12 months. Insulet Corporation [NASDAQ: PODD] shares were valued at $277.20 at the most recent close of the market. An investor can expect a potential drop of -3.32% based on the average PODD price forecast.
Analyzing the PODD fundamentals
Insulet Corporation [NASDAQ:PODD] reported sales of 1.98B for the trailing twelve months, which represents a growth of 25.70%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.46 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 272.81 points at the first support level, and at 268.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 280.78, and for the 2nd resistance point, it is at 284.36.
Ratios To Look Out For
For context, Insulet Corporation’s Current Ratio is 3.64. Further, the Quick Ratio stands at 2.76, while the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 9.80, the price to book ratio is 17.39 and price to earnings (TTM) ratio is 47.14.
Transactions by insiders
Recent insider trading involved Benjamin Eric, EVP, CPXPO, that happened on Jan 21 ’25 when 12394.0 shares were sold. Officer, Benjamin Eric completed a deal on Jan 21 ’25 to buy 12394.0 shares. Meanwhile, EVP, CPXPO Benjamin Eric sold 4362.0 shares on Dec 16 ’24.
